Kasparas Briedis, Egle Rumbinaite, Ali Aldujeli, Kamilija Briede, Martynas Jurenas, Povilas Jakuska, Antanas Jankauskas, Indre Ceponiene, Tadas Lenkutis, Jurgita Plisiene, Rimantas Benetis, Remigijus Zaliunas
BACKGROUND: The dry-pericardium Vienna transcatheter aortic valve system is repositionable and retrievable, already premounted on the delivery system, eliminating the need for assembly and crimping of the device before valve implantation. METHODS: The VIVA first-in-human feasibility study, a prospective, nonrandomized, single-center trial, evaluated the Vienna aortic valve in 10 patients with severe symptomatic aortic stenosis, who were at intermediate or high surgical risk...
April 9, 2024: Catheterization and Cardiovascular Interventions